9:30 AM
Introduction
Cole Manship, Product Strategy and Innovation at Memorial Sloan Kettering Cancer Center
9:35 AM
CancerX and USCDI+ Cancer
Stephen Konya, Chief, Innovation and Strategic Partnerships, Assistant Secretary for Technology Policy (ASTP), U.S. Department of Health and Human Services (HHS)
10:00 AM
Transforming Pain into Power: The Caregiver’s Role in Operationalizing Cancer Innovation
Erica Olenski, Vice President, FINN Partners
10:35 AM
Networking BREAK
11:00 AM
Bridging the Divide: Tackling Disparities in Cancer Trials and Access
Dr. Larry Norton, Senior VP, Office of the Hospital President, Memorial Sloan Kettering Cancer Center
11:30 AM
Immunogenik’s Vision for Next-Generation Immunotherapies: Precision, Modulation, and Impact
Dr. Jianping Huang, Founder & CEO, Immunogenik
12:00 PM
The Evolution of Oncology Navigation and How Technology Will Help
Steve Whitty, Co-Founder & CEO, BluePrint Nav
Tricia Strusowski, MS, RN Navigation Product Leader, Turnkey Oncology
12:30 PM
LUNCH
1:30 PM
Backing the Breakthroughs: Where Capital Meets Cancer Innovation
Rachel Ravens, CEO, 42Genetics, Partner at 46Health
Natalie Shtrizent, CEO, Frezent
Sian Farrell, CEO, StimOxyGen
Giuseppe Del Priore, CMO, BriaCell
2:00 PM
Accelerating Impact: Collaborations Fueling the Next Generation of Cancer Treatment
Rachel Ravens, CEO, 42Genetics, Partner at 46Health
Dr. Faisal Mahmood, Associate Prof of Pathology at Harvard Medical School and the Division of Computational Pathology at the Birmingham and Women’s Hospital
2:30 PM
NETWORKING BREAK
3:00 PM
Practical Applications for AI in Healthcare Workshop
Meg Columbia Walsh, Managing Director, Oberon Securities
3:30 PM
Practical Applications for AI in Healthcare Workshop
Meg Columbia Walsh, Managing Director, Oberon Securities
